Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual misoprostol versus intravenous oxytocin for management of the third stage of labor
IRCT138902293964N1Phase 2Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- Aug 2010
- Modality
- Recombinant Proteins and Enzymes, Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of misoprostol and oxytocin in postpartum hemorrhage (PPH) (2 arms), sponsored by Guilan University of Medical Sciences. Primary endpoints: Effect in management of the third stage of labor and Hemorrhage outcome. Started Aug 2010; status: completed.
02
Drugs
misoprostoloxytocin
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on IRCT138902293964N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138902293964N1.